Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
An error occurred in figure 4 of this paper by Simms-Williams and colleagues (BMJ 2024;385:e078242, doi:10.1136/bmj-2023-078242, published 25 April 2024). In table 3, “Mean (SD) duration of GLP-1 receptor agonist use, years” should be “Mean (SD) duration of SGLT-2inhibitor use, years.”
Read Original Article: Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study »
